899 filings
Page 11 of 45
D
goki1b9e
19 Dec 19
$26.42M in equity / options, sold $26.42M, 5 investors
4:30pm
8-K
i09d 68d5
11 Dec 19
Regulation FD Disclosure
4:48pm
8-K
yk13iud81ptlfrnjmrqq
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
zv7lkxe4ruy69h vk
28 Oct 19
Entry into a Material Definitive Agreement
4:40pm
8-K
loja goa0neegm
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
tuhwdr e9
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
DEF 14C
lgneocus 5349hw8y
18 Jul 19
Information statement
4:49pm
UPLOAD
o5dt5y99o
18 Jul 19
Letter from SEC
12:00am
PRER14C
ay82d3
17 Jul 19
Preliminary revised information
5:29pm
CORRESP
jykzm1quq8ke czx5m8w
17 Jul 19
Correspondence with SEC
12:00am
UPLOAD
93y359smb
3 Jul 19
Letter from SEC
12:00am
PRE 14C
1zbp6 h9kvo93gl
24 Jun 19
Preliminary information
4:25pm
8-K
ictfg sieu4ls
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
NT 10-Q/A
2nfae
16 May 19
Notice of late quarterly filing (amended)
9:46pm
EFFECT
fv0rlvckjwuiz
16 May 19
Notice of effectiveness
12:15am
NT 10-Q
qa2rdto4
15 May 19
Notice of late quarterly filing
4:34pm
CORRESP
2tnmxaug2q6bbpk
15 May 19
Correspondence with SEC
12:00am